Anti-tumor necrosis factor-α (anti-TNF-α) therapy is the most prescribed biologic therapy in rheumatology and gastroenterology. However, these therapies can cause serious side effects, including new-onset...
Anti-tumor necrosis factor-α (anti-TNF-α) therapy is the most prescribed biologic therapy in rheumatology and gastroenterology. However, these therapies can cause serious side effects, including new-onset...
In this study, researchers assessed patients with inflammatory bowel disease to determine why some did not respond to anti-TNF agents or had lost response over time. To see which factors may be involved...
In this study, researchers assessed patients with inflammatory bowel disease to determine why some did not respond to anti-TNF agents or had lost response over time. To see which factors may be involved...
Researchers examined the links between peripheral spondyloarthritis and Crohn disease, and how the gut microbiome can influence risk of the painful condition.
A recent placebo-controlled clinical trial tested the efficacy and safety of filgotinib in the treatment of patients with moderate to severe Crohn disease.